Tauns Laboratories (TSE:197A) Total Long-Term Assets: 円25,105 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
15 GF Score
Price 円502.00
! 9 Warning Signs
View Full Analysis

What is Tauns Laboratories Total Long-Term Assets?

Tauns Laboratories TSE:197A -1.57% 15 Total Long-Term Assets is 円25,105 Mil as of Mar. 2026. GuruFocus rates TSE:197A with a GF Score™ of 15/100. The stock has 9 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Tauns Laboratories's Total Long-Term Assets for the quarter that ended in Mar. 2026 was 円25,105 Mil.

Tauns Laboratories Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Total Long-Term Assets Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Total Long-Term Assets
8,232.45 8,875.25 12,345.61 21,038.69 25,355.99

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 21,038.69 24,220.59 25,290.52 25,105.02 25,355.99
TSE:197A
15GF Score
Tauns Laboratories Inc TSE:197A
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of 円25,105 Mil mean?
Tauns Laboratories (TSE:197A) has a Total Long-Term Assets of 円25,105 Mil as of Mar. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Total Long-Term Assets too high?
Tauns Laboratories' current Total Long-Term Assets is 円25,105 Mil. Overall, Tauns Laboratories has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Total Long-Term Assets compare to ISRG and BDX?
Tauns Laboratories' Total Long-Term Assets of 円25,105 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Total Long-Term Assets is 円25,105 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Total Long-Term Assets of 円25,105 Mil. The current Total Long-Term Assets is 円25,105 Mil. Tauns Laboratories' overall GF Score™ is 15/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Total Long-Term Assets is 円25,105 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
15GF Score

Get the complete analysis for TSE:197A

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円502.00
Price